Drug Research

Arranta Bio, part of Recipharm’s biologics business, has signed a contract with MIT to develop a continuous manufacturing technology for mRNA therapeutics. The contract is part of the FDA’s initiative to have a fully integrated, continuous manufacturing production line...

Charles River Laboratories International, Inc announced the launch of Accugenix® Next Generation Sequencing for Bacterial Identification and Fungal Identification. Accugenix NGS simultaneously sequences millions of individual DNA fragments from a sample and provides key information to pharmaceutical and personal...

Pfizer Inc. announced  that the U.S. FDA has approved PREVNAR 20 (20-valent Pneumococcal Conjugate Vaccine) for the prevention of invasive pneumococcal disease (IPD) caused by the 20 Streptococcus pneumoniae (pneumococcal) serotypes contained in the vaccine in infants and children six weeks...

Global research consortium is being set up to address the international impact of antimicrobial resistance (AMR). Significantly, the Centres for Antimicrobial Optimisation Network- CAMO-Net brings together research team from South Africa’s University of Cape Town, the University of Liverpool...

It is still difficult to get to the bottom of viral illnesses. Although isolated medicines exist that block virus multiplication in human cells, they are a significant exception. Against this backdrop, Prof. Reinhard Klein's from IMC Krems' Department of...

Research co-led by the University of Queensland has found that Australia is falling short of similar countries when it comes to funding basic research, specifically in the medical, biotechnology, and pharmaceutical arenas. The University of Queenland’s School of Chemical...

R21/Matrix-M happens to have a saponin-based adjuvant, Matrix-M, which goes on to enhance the immune response, thereby making it more viable and also durable. It is well to be noted that the adjuvant stimulates the entry of the antigen-presenting cells...